Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Cormio

Showing results (111-120 of 119) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 119 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Phase II study of cisplatin and vinorelbine as first-line chemotherapy in patients with carcinoma of the uterine cervixS Pignata, G Silvestro, E Ferrari, et al.
Gynecologic Oncology|July 19, 2017
Tertiary cytoreductive surgery in recurrent epithelial ovarian cancer: A multicentre MITO retrospective studyF Falcone, G Scambia, P Benedetti Panici, et al.
Gynecologic Oncology|June 14, 2019
Conservative surgery in stage I adult type granulosa cells tumors of the ovary: Results from the MITO-9 studyA Bergamini, G Cormio, G Ferrandina, et al.
Gynecologic Oncology|November 24, 2018
Early tumor regrowth is a contributor to impaired survival in patients with completely resected advanced ovarian cancer. An exploratory analysis of the Intergroup trial AGO-OVAR 12F Heitz, P Harter, E Åvall-Lundqvist, et al.
British Journal of Cancer|September 1, 2011
Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohortR Y Zang, P Harter, D S Chi, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 27, 2018
Laparoscopic surgery in the treatment of stage I adult granulosa cells tumors of the ovary: Results from the MITO-9 studyA Bergamini, G Ferrandina, M Candiani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2018
Expression III: patients' expectations and preferences regarding physician-patient relationship and clinical management-results of the international NOGGO/ENGOT-ov4-GCIG study in 1830 ovarian cancer patients from European countriesG Oskay-Özcelik, S Alavi, R Richter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 21, 2018
Quality-of-life analysis of the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study comparing platinum-based versus non-platinum-based chemotherapy in patients with partially platinum-sensitive recurrent ovarian cancerM C Piccirillo, G Scambia, A Bologna, et al.
ESMO Open|November 19, 2025
PARPi and myeloid neoplasms; the Italian MITO-MaNGO experience based on a multicentric surveyM Turinetto, C Marchetti, G Scandurra, et al.
Pageof 12

Showing results (111-120 of 119) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 119 results.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 10, 1999
Phase II study of cisplatin and vinorelbine as first-line chemotherapy in patients with carcinoma of the uterine cervixS Pignata, G Silvestro, E Ferrari, et al.
Gynecologic Oncology|July 19, 2017
Tertiary cytoreductive surgery in recurrent epithelial ovarian cancer: A multicentre MITO retrospective studyF Falcone, G Scambia, P Benedetti Panici, et al.
Gynecologic Oncology|June 14, 2019
Conservative surgery in stage I adult type granulosa cells tumors of the ovary: Results from the MITO-9 studyA Bergamini, G Cormio, G Ferrandina, et al.
Gynecologic Oncology|November 24, 2018
Early tumor regrowth is a contributor to impaired survival in patients with completely resected advanced ovarian cancer. An exploratory analysis of the Intergroup trial AGO-OVAR 12F Heitz, P Harter, E Åvall-Lundqvist, et al.
British Journal of Cancer|September 1, 2011
Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohortR Y Zang, P Harter, D S Chi, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|March 27, 2018
Laparoscopic surgery in the treatment of stage I adult granulosa cells tumors of the ovary: Results from the MITO-9 studyA Bergamini, G Ferrandina, M Candiani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 8, 2018
Expression III: patients' expectations and preferences regarding physician-patient relationship and clinical management-results of the international NOGGO/ENGOT-ov4-GCIG study in 1830 ovarian cancer patients from European countriesG Oskay-Özcelik, S Alavi, R Richter, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 21, 2018
Quality-of-life analysis of the MITO-8, MaNGO, BGOG-Ov1, AGO-Ovar2.16, ENGOT-Ov1, GCIG study comparing platinum-based versus non-platinum-based chemotherapy in patients with partially platinum-sensitive recurrent ovarian cancerM C Piccirillo, G Scambia, A Bologna, et al.
ESMO Open|November 19, 2025
PARPi and myeloid neoplasms; the Italian MITO-MaNGO experience based on a multicentric surveyM Turinetto, C Marchetti, G Scandurra, et al.
Pageof 12